Which has grown faster, SGRY or SRPT?

Over the past five years, SRPT grew revenue faster — SGRY at a 9.90% CAGR versus SRPT at 26.90%.

How have SGRY and SRPT total returns compared?

Over the past 10 years, SGRY delivered -3.96% and SRPT delivered -11.94% annualized total return. Past performance doesn't predict future results.

Surgery Partners, Inc. (SGRY) vs Sarepta Therapeutics, Inc. (SRPT)

A side-by-side comparison of Surgery Partners, Inc. and Sarepta Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

SGRY

Surgery Partners, Inc.

$1.77B

$13.50HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

SRPT

Sarepta Therapeutics, Inc.

$1.82B

$17.25HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

Total return — SGRY vs SRPT

growth of $100 · dividends reinvested · last 10y

SGRY -31.9% (-3.8%/yr)SRPT -71.5% (-11.8%/yr)SGRY compounded faster over this window

SGRY SRPT

SGRY vs SRPT: by the numbers

•SRPT is the larger company ($1.82B vs $1.77B market cap).
•Both run net losses; SGRY's is the smaller (-2.63% vs -6.93% net margin).
•SRPT grew revenue faster over the past five years (26.90% vs 9.90% CAGR).

Metrics side by side

Valuation

Metric	SGRY	SRPT
Forward P/E	33.17	5.36
P/S ratio	0.52	0.92
P/B ratio	1.06	1.19
EV / EBITDA	9.64	N/A
FCF yield	10.63%	N/A

Profitability

Metric	SGRY	SRPT
Gross margin	21.37%	58.56%
Operating margin	11.89%	-29.92%
Net margin	-2.63%	-6.93%
ROE	-5.30%	-8.95%
ROIC	4.23%	-5.33%

Growth (annualized)

Metric	SGRY	SRPT
Revenue CAGR (5Y)	9.90%	26.90%
FCF CAGR (5Y)	-0.84%	N/A
Total return CAGR (5Y)	-20.85%	-28.74%

Frequently asked

Which has grown faster, SGRY or SRPT?: Over the past five years, SRPT grew revenue faster — SGRY at a 9.90% CAGR versus SRPT at 26.90%.
How have SGRY and SRPT total returns compared?: Over the past 10 years, SGRY delivered -3.96% and SRPT delivered -11.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full SGRY analysis Full SRPT analysis Interactive comparison tool

Dig into the metrics

Surgery Partners ROE Sarepta Therapeutics ROE Surgery Partners operating margin Sarepta Therapeutics operating margin Surgery Partners revenue growth Sarepta Therapeutics revenue growth Surgery Partners free cash flow Sarepta Therapeutics free cash flow

Surgery Partners & Sarepta Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.